Qualitative differentiation of positive inotropic effects of isoprenaline and 8-bromo-cAMP in isolated rat atria *1Timo Mets�-Ketel�. Department of Biomedical Sciences, University of Tampere, Tampere, Finland

1981 ◽  
Vol 13 ◽  
pp. 58
2001 ◽  
Vol 169 (1) ◽  
pp. 177-183 ◽  
Author(s):  
K Terui ◽  
A Higashiyama ◽  
N Horiba ◽  
KI Furukawa ◽  
S Motomura ◽  
...  

Corticotropin-releasing factor (CRF) has a coronary vasodilator effect and a positive inotropic effect on the isolated rat heart. Recently, expression of CRF receptor type 2 (CRF-R2) has been demonstrated in the heart. In addition, urocortin (Ucn), a new member of the CRF family, has been reported to have much greater affinity for CRF-R2 than CRF. It is suggested that the cardiac effects of Ucn may be more potent than those of CRF. We compared the effect of Ucn with that of CRF on isolated rat heart. The effects of Ucn were then analyzed to determine whether these effects were mediated by CRF receptors and/or any other mediators under the following conditions: perfusion buffer containing (1) alpha-helical CRF 9-41, (2) indomethacin, (3) N(G)-nitro-l -arginine methylester and (4) propranolol. Ucn exhibited a greater effect with a longer duration of action than CRF. Indomethacin significantly attenuated the vasodilator effects of Ucn (P<0.05). CRF receptor antagonist diminished both coronary vasodilation and the positive inotropic effects of Ucn (P<0.05). These results suggest that the cardiac effects of Ucn may be mediated by a CRF receptor, and prostaglandins may be involved in the vasodilator effect.


1982 ◽  
Vol 32 (2) ◽  
pp. 221-230 ◽  
Author(s):  
Atsuko HIRANO ◽  
Hisakuni HASHIMOTO ◽  
Mitsuyoshi NAKASHIMA

2002 ◽  
Vol 25 (2) ◽  
pp. 197-200 ◽  
Author(s):  
Yoko Kubota ◽  
Keizo Umegaki ◽  
Naoko Tanaka ◽  
Hideya Mizuno ◽  
Kazuki Nakamura ◽  
...  

1987 ◽  
Vol 65 (6) ◽  
pp. 1227-1233 ◽  
Author(s):  
M. Wlllerth ◽  
J. A. Thornhill

The possible inotropic effects of all three classes of endogenous opioids were tested alone or in combination with noradrenaline, adrenaline, or carbachol on electrically stimulated atria isolated from male Sprague–Dawley rats. Noradrenaline (6.0 and 12 μM) and adrenaline (4.0 and 8.0 μM) injections caused marked but transient (5 min) dose-related increases in atrial tension compared with preinjection control values, whereas carbachol (0.14 and 1.4 μM) caused a more potent and prolonged (over 15 min) dose-related decrease in atrial tension development. Adrenal enkephalins (0.3–4.0 μM) of methionine enkephalin, leucine enkephalin, Met-enkephalin-Arg6-Phe7, and Met-enkephalin-Arg6-Gly7-Leu8, β-endorphin (0.2–2.0 μM), or dynorphin A(1–13) (0.2–2.0 μM) did not change atrial tension for a 15-min postadministration test period. In addition, these opioids did not affect the positive inotropic effects of noradrenaline (12 μM) or adrenaline (8.0 μM) or the negative inotropic actions of carbachol (1.4 μM) when the same doses of noradrenaline, adrenaline, or carbachol were given alone. These data indicate that endogenous opioids given in micromolar concentrations tested did not affect atrial tension development of electrically stimulated rat atria. Comparing these data with those of past literature, it is suggested that circulating endogenous opioids probably do not have any direct effects on the rat myocardium to affect myocardial contractility.


Sign in / Sign up

Export Citation Format

Share Document